Cell-Based Production of Nonulosonates

US2017145459A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017145459-A1
Application numberUS-201615354603-A
CountryUS
Kind codeA1
Filing dateNov 17, 2016
Priority dateApr 20, 2010
Publication dateMay 25, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the cell-based production of bacterial nonulosonates and their biosynthetic precursors. Specifically, the present invention provides recombinant cells for the production of pseudaminic acid, legionaminic acid, UDP-2,4-diacetamido-2,4,6-trideoxy-β-L-altropyranose, and UDP-2,4-diacetamido-2,4,6-trideoxy-α-D-glucopyranose. Methods for producing the sugars are also provided.

First claim

Opening claim text (preview).

1 . A recombinant cell for the production of legionaminic acid, comprising an inactivated GlcNAc-6-P deacetylase gene, a gene encoding a PglF enzyme function, a gene encoding a PglE enzyme function, a gene encoding a PglD enzyme function, a gene encoding a LegI enzyme function, a gene encoding a LegG enzyme function, a gene encoding a GlcNAc-6-P mutase, and a gene encoding a GlcNAc-1-P uridyltransferase. 2 . The recombinant cell of claim 1 , wherein the PglF, PglE, and PglD enzyme functions are genes from C. jejuni , the LegI enzyme function is from C. jejuni or L. pneumophila , the LegG enzyme function is a gene from L. pneumophila LegG, and the GlcNAc-6-P mutase and GlcNAc-1-P uridyltransferase genes are from S. cerevisiae. 3 . The recombinant cell of claim 1 , further comprising at least one of an inactivated sialic acid transporter gene, an inactivated sialic acid aldolase gene. 4 . The recombinant cell of claim 1 , further comprising at least one of an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated wecA undecaprenyl-P/UDP-GlcNAc transferase gene, an inactivated nanE ManNAc-6-P epimerase gene or a gene encoding an acetyl-CoA synthase. 5 . The recombinant cell of claim 1 , wherein the cell is an E. coli cell. 6 . The recombinant cell of claim 1 , wherein the recombinant cell is an E. coli cell further comprising an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated nagA GlcNAc-6-P deacetylase gene, a PglF gene encoding SEQ ID NO:6, a PglE gene encoding SEQ ID NO:7, a PglD gene encoding SEQ ID NO:8, a LegI gene encoding SEQ ID NO:9 or SEQ ID NO:10, a LegG gene encoding SEQ ID NO:11, the agm1 GlcNAc-6-P mutase gene, and the uap1 GlcNAc-1-P uridyltransferase gene. 7 . The recombinant cell of claim 1 , further comprising at least one of an inactivated ManNAc-6-P epimerase gene or an inactivated undecaprenyl-P/UDP-GlcNAc transferase gene. 8 . The recombinant cell of claim 7 , wherein the ManNAc-6-P epimerase gene is nanE, and the undecaprenyl-P/UDP-GlcNAc transferase gene is wecA. 9 . A method for the production of legionaminic acid, comprising growing the recombinant cell of claim 1 and recovering the produced legionaminic acid. 10 . The method of claim 9 , wherein growth medium for the recombinant cell is supplemented with palmitate. 11 . A recombinant cell for the production of UDP-2,4-diacetamido-2,4,6-trideoxy-α-D-glucopyranose (UDP-BacdiNAc), comprising an inactivated GlcNAc-6-P deacetylase gene, a gene encoding a PglF enzyme function, a gene encoding a PglE enzyme function, a gene encoding a PglD enzyme function, a gene encoding a GlcNAc-6-P mutase, and a gene encoding a GlcNAc-1-P uridyltransferase. 12 . The recombinant cell of claim 11 , wherein the PglF, PglE, and PglD genes are from C. jejuni , and the GlcNAc-6-P mutase and GlcNAc-1-P uridyltransferase genes are from S. cerevisiae. 13 . The recombinant cell of claim 11 , further comprising at least one of an inactivated sialic acid transporter gene or an inactivated sialic acid aldolase gene. 14 . The recombinant cell of claim 11 , further comprising at least one of an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated wecA undecaprenyl-P/UDP-GlcNAc transferase gene or a gene encoding acetyl-CoA synthase. 15 . The recombinant cell of claim 11 , wherein the recombinant cell is an E. coli cell further comprising an inactivated nanT sialic acid transporter gene, an inactivated nanA sialic acid aldolase gene, an inactivated nagA GlcNAc-6-P deacetylase gene, a PglF gene encoding SEQ ID NO:6, a PglE gene encoding SEQ ID NO:7, a PglD gene encoding SEQ ID NO:8, the agm1GlcNAc-6-P mutase gene, and the uap1 GlcNAc-1-P uridyltransferase gene. 16 . The recombinant cell of claim 11 , wherein the cell is an E. coli cell. 17 . The recombinant cell for the production of UDP-BacdiNAc of claim 11 , wherein the cell is that of IDAC deposit No. 060411-01. 18 . A method for the production of UDP-2,4-diacetamido-2,4,6-trideoxy-α-D-glucopyranose (UDP-BacdiNAc), comprising growing the recombinant cell of claim 11 and recovering the produced UDP-BacdiNAc. 19 . The method of claim 18 , wherein growth medium for the recombinant cell is supplemented with palmitate.

Assignees

Inventors

Classifications

  • UDP-sugar diphosphatase (3.6.1.45) · CPC title

  • C12P19/26Primary

    Preparation of nitrogen-containing carbohydrates · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • N-Acetylglucosamine-6-phosphate deacetylase (3.5.1.25) · CPC title

  • Vectors or expression systems specially adapted for E. coli · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017145459A1 cover?
The present invention relates to the cell-based production of bacterial nonulosonates and their biosynthetic precursors. Specifically, the present invention provides recombinant cells for the production of pseudaminic acid, legionaminic acid, UDP-2,4-diacetamido-2,4,6-trideoxy-β-L-altropyranose, and UDP-2,4-diacetamido-2,4,6-trideoxy-α-D-glucopyranose. Methods for producing the sugars are also …
Who is the assignee on this patent?
Nat Res Council Canada, Univ Ottawa
What technology area does this patent fall under?
Primary CPC classification C12P19/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).